1. Clinical & Scientific Overview
Valacyclovir Hydrochloride IP (TIP-MED-000326, Reference Code [8.14]-CMP56) is classified under
Antimicrobials — Antiviral & Antiretroviral Agents (Ch 08) as a Synthetic Purine Nucleoside Analogue Antiviral (Activated by Viral Thymidine Kinase to Inhibit Herpesvirus DNA Polymerase).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
L-valyl ester oral prodrug of Acyclovir (Valcivir 500/1000 mg) absorbed via PepT1 with ~55% oral bioavailability.
Standard approved strengths (refer to comparative context)
3. Mechanism of Action & Pharmacodynamics
L-valyl ester oral prodrug of Acyclovir (Valcivir 500/1000 mg) absorbed via PepT1 with ~55% oral bioavailability.
4. Therapeutic Indications & Evidence-Supported Uses
- Herpes Zoster (Shingles—requires high-dose 800 mg 5 times daily!) and Varicella (Chickenpox)
- mucocutaneous and genital Herpes Simplex Virus (HSV-1 and HSV-2) treatment and suppression
- HSV keratitis (3% eye ointment) and HSV encephalitis (IV)
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: L-valyl ester oral prodrug of Acyclovir (Valcivir 500/1000 mg) absorbed via PepT1 with ~55% oral bioavailability.
Administration & Meal Timing: With or without food, accompanied by a FULL GLASS OF WATER with every single tablet! | 5 times daily (every 4 hours while awake: 7 AM, 11 AM, 3 PM, 7 PM, 11 PM) for Shingles; 3 times daily (every 8 hours) for HSV.
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Comparative pharmacokinetic profile co-indexed under [8.14].
Renal: STRICTLY RENAL-FUNCTION DEPENDENT (Excreted 65–90% unchanged in urine; t1/2 jumps from 2.5 h to 20 h in renal failure)! For Herpes Zoster (800 mg regimen): • CrCl >25 mL/min: 800 mg every 4 hours (5 times daily). • CrCl 10–25 mL/min: 800 mg THREE times daily (every 8 hours)! • CrCl <10 mL/min: 800 mg TWICE daily (every 12 hours)! (Similarly, for Valacyclovir in Zoster: CrCl ≥50: 1000 mg TDS; CrCl 30–49: 1000 mg BD; CrCl 10–29: 1000 mg OD; CrCl <10: 500 mg OD). Hepatic: No dose adjustment needed.
Renal: STRICTLY RENAL-FUNCTION DEPENDENT (Excreted 65–90% unchanged in urine; t1/2 jumps from 2.5 h to 20 h in renal failure)! For Herpes Zoster (800 mg regimen): • CrCl >25 mL/min: 800 mg every 4 hours (5 times daily). • CrCl 10–25 mL/min: 800 mg THREE times daily (every 8 hours)! • CrCl <10 mL/min: 800 mg TWICE daily (every 12 hours)! (Similarly, for Valacyclovir in Zoster: CrCl ≥50: 1000 mg TDS; CrCl 30–49: 1000 mg BD; CrCl 10–29: 1000 mg OD; CrCl <10: 500 mg OD). Hepatic: No dose adjustment needed.
Renal: STRICTLY RENAL-FUNCTION DEPENDENT (Excreted 65–90% unchanged in urine; t1/2 jumps from 2.5 h to 20 h in renal failure)! For Herpes Zoster (800 mg regimen): • CrCl >25 mL/min: 800 mg every 4 hours (5 times daily). • CrCl 10–25 mL/min: 800 mg THREE times daily (every 8 hours)! • CrCl <10 mL/min: 800 mg TWICE daily (every 12 hours)! (Similarly, for Valacyclovir in Zoster: CrCl ≥50: 1000 mg TDS; CrCl 30–49: 1000 mg BD; CrCl 10–29: 1000 mg OD; CrCl <10: 500 mg OD). Hepatic: No dose adjustment needed.
7. Contraindications, Precautions & High-Risk Warnings
- 1. Crystal-Induced Obstructive Acute Kidney Injury (Crystalluria): Acyclovir has low solubility in urine; high doses (800 mg 5x/day or rapid IV infusion) in dehydrated or elderly patients precipitate as needle-shaped crystals inside renal tubules! 2. Acyclovir Neurotoxicity in Renal Impairment: Unadjusted doses in CKD cause acute encephalopathy!
Key Clinical Precautions: Renal: STRICTLY RENAL-FUNCTION DEPENDENT (Excreted 65–90% unchanged in urine; t1/2 jumps from 2.5 h to 20 h in renal failure)! For Herpes Zoster (800 mg regimen): • CrCl >25 mL/min: 800 mg every 4 hours (5 times daily). • CrCl 10–25 mL/min: 800 mg THREE times daily (every 8 hours)! • CrCl <10 mL/min: 800 mg TWICE daily (every 12 hours)! (Similarly, for Valacyclovir in Zoster: CrCl ≥50: 1000 mg TDS; CrCl 30–49: 1000 mg BD; CrCl 10–29: 1000 mg OD; CrCl <10: 500 mg OD). Hepatic: No dose adjustment needed.
8. Adverse Effects Profile
- Nausea, headache, mild diarrhoea, malaise, local stinging with topical/ophthalmic application.
- Crystal-induced Acute Kidney Injury / Obstructive Nephropathy, Acyclovir/Valacyclovir Neurotoxicity (occurs within 24–72 hours in elderly patients with reduced eGFR: confusion, agitation, dysarthria, visual hallucinations, myoclonus, ataxia, and coma—often misdiagnosed as Herpes Zoster encephalitis!), thrombotic thrombocytopenic purpura (high-dose in immunocompromised).
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Nephrotoxic Drugs (NSAIDs like diclofenac/ibuprofen, aminoglycosides, cyclosporine, tenofovir) markedly increase the risk of acyclovir crystal nephropathy and neurotoxicity! Probenecid, cimetidine, and mycophenolate mofetil compete for renal tubular OAT secretion, increasing plasma acyclovir levels
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical parameters per parent class monograph [8.14].
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: When dispensing Acivir 800 DT / Zovirax 800 for Shingles (Herpes Zoster): 1. Write out the exact 5-times-daily clock schedule (7 AM, 11 AM, 3 PM, 7 PM, 11 PM) so the patient does not wake up at 3 AM. 2. Dispersible tablets (Acivir 800 DT) can be dispersed in 50 mL of water or swallowed whole with a full glass of water. 3. Insist on drinking at least 8–10 glasses of water daily to protect the kidneys. 4. Tell family caregivers to report immediately if the elderly patient becomes confused, drowsy, or starts seeing things (hallucinations), as that means the antiviral dose is too high for their kidneys.
- Meal & Clock Timing Instruction: With or without food, accompanied by a FULL GLASS OF WATER with every single tablet! (5 times daily (every 4 hours while awake: 7 AM, 11 AM, 3 PM, 7 PM, 11 PM) for Shingles; 3 times daily (every 8 hours) for HSV.)
- Missed Dose Protocol: Take as soon as remembered with a full glass of water; never double the dose.
- Geriatric Dispensing Pearl: Herpes Zoster (Shingles) is overwhelmingly a disease of elderly and diabetic CGHS patients. Always calculate CrCl before dispensing 800 mg 5x/day Acyclovir or 1000 mg TDS Valacyclovir to a patient >70 years, and avoid co-prescribing NSAIDs (use Paracetamol + low-dose Pregabalin/Gabapentin for acute zoster pain instead, so NSAIDs do not precipitate acyclovir renal failure!).
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Uncoated / Dispersible Tablets: 200 mg, 400 mg, 800 mg; Oral Suspension: 200 mg/5 mL, 400 mg/5 mL; Topical Cream: 5% w/w; Ophthalmic Ointment: 3% w/w; IV Infusion: 250 mg, 500 mg vials
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [8.35] Oseltamivir Phosphate — Influenza A & B Viral Neuraminidase Inhibitor (Schedule H1 | NLEM
- [8.36] Tenofovir Disoproxil Fumarate (TDF), Entecavir & Dolutegravir-Based ART (TLD) — Nucleotide/Nucleoside Reverse Transcriptase Inhibitors & Integras
- [8.36]-C78 Entecavir — Nucleotide/Nucleoside Reverse Transcriptase Inhibitors & Integras
- [8.36]-C79 Tenofovir + Lamivudine + Dolutegravir (TLD ART FDC) — Nucleotide/Nucleoside Reverse Transcriptase Inhibitors & Integras